
### [MONDO:0019685](http://purl.obolibrary.org/obo/MONDO_0019685)
**Label:** FGFR3-related chondrodysplasia

**Subclasses:** [MONDO:0007037](http://purl.obolibrary.org/obo/MONDO_0007037) (achondroplasia), [MONDO:0007994](http://purl.obolibrary.org/obo/MONDO_0007994) (micromelic bone dysplasia with cloverleaf skull), [MONDO:0007793](http://purl.obolibrary.org/obo/MONDO_0007793) (hypochondroplasia), [MONDO:0010114](http://purl.obolibrary.org/obo/MONDO_0010114) (thanatophoric dysplasia, glasgow variant), [MONDO:0017042](http://purl.obolibrary.org/obo/MONDO_0017042) (thanatophoric dysplasia), [MONDO:0008546](http://purl.obolibrary.org/obo/MONDO_0008546) (thanatophoric dysplasia type 1), [MONDO:0008547](http://purl.obolibrary.org/obo/MONDO_0008547) (thanatophoric dysplasia type 2), [MONDO:0012504](http://purl.obolibrary.org/obo/MONDO_0012504) (camptodactyly-tall stature-scoliosis-hearing loss syndrome), [MONDO:0014658](http://purl.obolibrary.org/obo/MONDO_0014658) (severe achondroplasia-developmental delay-acanthosis nigricans syndrome), 

**Mapped go classes:** [GO:0018108](http://purl.obolibrary.org/obo/GO_0018108) (peptidyl-tyrosine phosphorylation), [GO:0048839](http://purl.obolibrary.org/obo/GO_0048839) (inner ear development), [GO:0046777](http://purl.obolibrary.org/obo/GO_0046777) (protein autophosphorylation), [GO:0048712](http://purl.obolibrary.org/obo/GO_0048712) (negative regulation of astrocyte differentiation), [GO:0008543](http://purl.obolibrary.org/obo/GO_0008543) (fibroblast growth factor receptor signaling pathway), [GO:0048678](http://purl.obolibrary.org/obo/GO_0048678) (response to axon injury), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0042531](http://purl.obolibrary.org/obo/GO_0042531) (positive regulation of tyrosine phosphorylation of STAT protein), [GO:0002089](http://purl.obolibrary.org/obo/GO_0002089) (lens morphogenesis in camera-type eye), [GO:0022010](http://purl.obolibrary.org/obo/GO_0022010) (central nervous system myelination), [GO:0001501](http://purl.obolibrary.org/obo/GO_0001501) (skeletal system development), [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0048640](http://purl.obolibrary.org/obo/GO_0048640) (negative regulation of developmental growth), [GO:0031398](http://purl.obolibrary.org/obo/GO_0031398) (positive regulation of protein ubiquitination), [GO:0072148](http://purl.obolibrary.org/obo/GO_0072148) (epithelial cell fate commitment), [GO:0030501](http://purl.obolibrary.org/obo/GO_0030501) (positive regulation of bone mineralization), [GO:0060113](http://purl.obolibrary.org/obo/GO_0060113) (inner ear receptor cell differentiation), [GO:0038066](http://purl.obolibrary.org/obo/GO_0038066) (p38MAPK cascade), [GO:0090102](http://purl.obolibrary.org/obo/GO_0090102) (cochlea development), [GO:0090263](http://purl.obolibrary.org/obo/GO_0090263) (positive regulation of canonical Wnt signaling pathway), [GO:0007267](http://purl.obolibrary.org/obo/GO_0007267) (cell-cell signaling), [GO:0043552](http://purl.obolibrary.org/obo/GO_0043552) (positive regulation of phosphatidylinositol 3-kinase activity), [GO:0004672](http://purl.obolibrary.org/obo/GO_0004672) (protein kinase activity), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005764](http://purl.obolibrary.org/obo/GO_0005764) (lysosome), [GO:0010629](http://purl.obolibrary.org/obo/GO_0010629) (negative regulation of gene expression), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0002009](http://purl.obolibrary.org/obo/GO_0002009) (morphogenesis of an epithelium), [GO:0050680](http://purl.obolibrary.org/obo/GO_0050680) (negative regulation of epithelial cell proliferation), [GO:0017134](http://purl.obolibrary.org/obo/GO_0017134) (fibroblast growth factor binding), [GO:0030133](http://purl.obolibrary.org/obo/GO_0030133) (transport vesicle), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), [GO:0060385](http://purl.obolibrary.org/obo/GO_0060385) (axonogenesis involved in innervation), [GO:0061430](http://purl.obolibrary.org/obo/GO_0061430) (bone trabecula morphogenesis), [GO:0014003](http://purl.obolibrary.org/obo/GO_0014003) (oligodendrocyte development), [GO:1902178](http://purl.obolibrary.org/obo/GO_1902178) (fibroblast growth factor receptor apoptotic signaling pathway), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0060349](http://purl.obolibrary.org/obo/GO_0060349) (bone morphogenesis), [GO:0006468](http://purl.obolibrary.org/obo/GO_0006468) (protein phosphorylation), [GO:0043525](http://purl.obolibrary.org/obo/GO_0043525) (positive regulation of neuron apoptotic process), [GO:0009898](http://purl.obolibrary.org/obo/GO_0009898) (cytoplasmic side of plasma membrane), [GO:0060348](http://purl.obolibrary.org/obo/GO_0060348) (bone development), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0000122](http://purl.obolibrary.org/obo/GO_0000122) (negative regulation of transcription by RNA polymerase II), [GO:0005007](http://purl.obolibrary.org/obo/GO_0005007) (fibroblast growth factor-activated receptor activity), [GO:0000165](http://purl.obolibrary.org/obo/GO_0000165) (MAPK cascade), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0090080](http://purl.obolibrary.org/obo/GO_0090080) (positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0004713](http://purl.obolibrary.org/obo/GO_0004713) (protein tyrosine kinase activity), [GO:0004714](http://purl.obolibrary.org/obo/GO_0004714) (transmembrane receptor protein tyrosine kinase activity), [GO:0045670](http://purl.obolibrary.org/obo/GO_0045670) (regulation of osteoclast differentiation), [GO:0010518](http://purl.obolibrary.org/obo/GO_0010518) (positive regulation of phospholipase activity), [GO:0035019](http://purl.obolibrary.org/obo/GO_0035019) (somatic stem cell population maintenance), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0010712](http://purl.obolibrary.org/obo/GO_0010712) (regulation of collagen metabolic process), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0070307](http://purl.obolibrary.org/obo/GO_0070307) (lens fiber cell development), [GO:0050731](http://purl.obolibrary.org/obo/GO_0050731) (positive regulation of peptidyl-tyrosine phosphorylation), [GO:0061144](http://purl.obolibrary.org/obo/GO_0061144) (alveolar secondary septum development), [GO:0036342](http://purl.obolibrary.org/obo/GO_0036342) (post-anal tail morphogenesis), [GO:0045839](http://purl.obolibrary.org/obo/GO_0045839) (negative regulation of mitotic nuclear division), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0030282](http://purl.obolibrary.org/obo/GO_0030282) (bone mineralization), [GO:0048546](http://purl.obolibrary.org/obo/GO_0048546) (digestive tract morphogenesis), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0045597](http://purl.obolibrary.org/obo/GO_0045597) (positive regulation of cell differentiation), [GO:0043410](http://purl.obolibrary.org/obo/GO_0043410) (positive regulation of MAPK cascade), [GO:0045879](http://purl.obolibrary.org/obo/GO_0045879) (negative regulation of smoothened signaling pathway), [GO:0021762](http://purl.obolibrary.org/obo/GO_0021762) (substantia nigra development), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0070371](http://purl.obolibrary.org/obo/GO_0070371) (ERK1 and ERK2 cascade), [GO:0048471](http://purl.obolibrary.org/obo/GO_0048471) (perinuclear region of cytoplasm), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0046850](http://purl.obolibrary.org/obo/GO_0046850) (regulation of bone remodeling), [GO:0070374](http://purl.obolibrary.org/obo/GO_0070374) (positive regulation of ERK1 and ERK2 cascade), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0071864](http://purl.obolibrary.org/obo/GO_0071864) (positive regulation of cell proliferation in bone marrow), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0001938](http://purl.obolibrary.org/obo/GO_0001938) (positive regulation of endothelial cell proliferation), [GO:0070977](http://purl.obolibrary.org/obo/GO_0070977) (bone maturation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0030278](http://purl.obolibrary.org/obo/GO_0030278) (regulation of ossification), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), 

**Class expressions from DL-Learner:**

- Thing 53.13%
- [GO:1902178](http://purl.obolibrary.org/obo/GO_1902178) (fibroblast growth factor receptor apoptotic signaling pathway) 52.08%
- [GO:0090102](http://purl.obolibrary.org/obo/GO_0090102) (cochlea development) 52.08%
- [GO:0070977](http://purl.obolibrary.org/obo/GO_0070977) (bone maturation) 52.08%
- [GO:0070371](http://purl.obolibrary.org/obo/GO_0070371) (ERK1 and ERK2 cascade) 52.08%
- [GO:0070307](http://purl.obolibrary.org/obo/GO_0070307) (lens fiber cell development) 52.08%
- [GO:0061430](http://purl.obolibrary.org/obo/GO_0061430) (bone trabecula morphogenesis) 52.08%
- [GO:0061383](http://purl.obolibrary.org/obo/GO_0061383) (trabecula morphogenesis) 52.08%
- [GO:0061144](http://purl.obolibrary.org/obo/GO_0061144) (alveolar secondary septum development) 52.08%
- [GO:0060385](http://purl.obolibrary.org/obo/GO_0060385) (axonogenesis involved in innervation) 52.08%
- [GO:0038066](http://purl.obolibrary.org/obo/GO_0038066) (p38MAPK cascade) 52.08%
- [GO:0036342](http://purl.obolibrary.org/obo/GO_0036342) (post-anal tail morphogenesis) 52.08%
- [GO:0032291](http://purl.obolibrary.org/obo/GO_0032291) (axon ensheathment in central nervous system) 52.08%
- [GO:0030900](http://purl.obolibrary.org/obo/GO_0030900) (forebrain development) 52.08%
- [GO:0022010](http://purl.obolibrary.org/obo/GO_0022010) (central nervous system myelination) 52.08%


